Abstract： Objective To investigate the application of thoracoscopic pulmonary rehabilitation in perioperative period of lung cancer. Methods A total of 100 lung cancer patients who were selected from February 2020 to February 2021 in Department of Thoracic Surgery, the First People′s Hospital of Jiujiang City were retrospectively selected as the subjects. According to the perioperative treatment methods, 100 patients were divided into control group and observation group. The surgeries were performed by doctors in the same treatment group. Both groups received routine perioperative treatment of thoracoscopic lung cancer surgery, and the observation group received perioperative pulmonary rehabilitation treatment on the basis of the control group. The incidence of postoperative pulmonary complications (including pulmonary infection and empyema), postoperative hospital stay, forced expiratory volume in the first second (FEV1), maximum ventilation (MVV) and 6 min walking test (6MWT) were measured and recorded between the two groups. Results The incidence of postoperative pulmonary complications in the observation group was 12.00% (6/50), lower than 64.00% (27/50) in the control group, the difference was statistically significant (P＜0.05). The length of stay in the observation group was shorter than that in the control group, the difference was statistically significant (P＜0.05). The FEV1, MVV and 6MWT of the two groups after intervention were higher than those before intervention, the FEV1, MVV and 6MWT of the observation group after intervention were higher than those of the control group, the differences were statistically significant (P＜0.05). Conclusion The application effect of thoracoscopy in lung cancer perioperative period is good.
Hamann HA，Ver Hoeve ES，Carter-Harris L，et al.Multilevel Opportunities to Address Lung Cancer Stigma across the Cancer Control Continuum[J].J Thorac Oncol，2018，13（8）：1062-1075.
[5]
Yu L，Xiao Z，Tu H，et al.The expression and prognostic significance of Drp1 in lung cancer：A bioinformatics analysis and immunohistochemistry[J].Medicine（Baltimore），2019，98（48）：18228.
[6]
Wei S，Chen F，Liu R，et al.Outcomes of lobectomy on pulmonary function for early stage non-small cell lung cancer（NSCLC）patients with chronic obstructive pulmonary disease（COPD）[J].Thorac Cancer，2020，11（7）：1784-1789.
Ha D，Ries AL，Mazzone PJ，et al.Exercise capacity and cancer-specific quality of life following curative intent treatment of stage Ⅰ-ⅢA lung cancer[J].Support Care Cancer，2018，26（7）：2459-2469.
[10]
Spiro SG，Shah PL，Rintoul RC，et al.Sequential screening for lung cancer in a high-risk group：randomised controlled trial：LungSEARCH：a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group[J].Eur Respir J，2019，54（4）：1900581.
[12]
Nigro E，Perrotta F，ScialòF，et al.Food，Nutrition，Physical Activity and Microbiota：Which Impact on Lung Cancer?[J].Int J Environ Res Public Health，2021，18（5）：2399.
京公网安备 11010502046607号